CoChat
Sign Up
Cited by 134Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence

ELLIS, KEITH, WAZNI, OUSSAMA, MARROUCHE, NASSIR, MARTIN, DAVID, GILLINOV, MARC, McCARTHY, PATRICK, SAAD, EDUARDO B., BHARGAVA, MANDEEP, SCHWEIKERT, ROBERT, SALIBA, WALID, BASH, DIANNA, ROSSILLO, ANTONIO, ERCIYES, DEMET, TCHOU, PATRICK, NATALE, ANDREA·2007·Journal of Cardiovascular Electrophysiology
DOI 10.1111/j.1540-8167.2007.00885.x
Open this paper in CoChat — free account

Abstract

INTRODUCTION: Atrial fibrillation and atrial flutter often coexist. The long-term occurrence of atrial fibrillation in patients presenting with atrial flutter alone is unknown. We report the long-term follow-up in patients who underwent cavotricuspid isthmus ablation for treatment of lone atrial flutter. METHODS AND RESULTS: Between January 1997 and June 2002, 632 patients underwent cavotricuspid isthmus ablation for the treatment of typical atrial flutter at the Cleveland Clinic Foundation. Three hundred sixty-three patients were included in this study and followed for a mean duration of 39 +/- 11 months. The mean duration of atrial flutter symptoms was 12 +/- 5 months. Mean left-atrial size and left-ventricular ejection fraction were 4.2 +/- 0.8 cm and 47 +/- 13%, respectively. After a mean follow-up time of 39 +/- 11 months, 13% (48 of 363) of the patients remained in sinus rhythm. Five percent (18 of 363) of patients experienced recurrence of atrial flutter only. Sixty-eight percent (246 of 363) experienced the onset of atrial fibrillation and 14% (51 of 363) experienced recurrence of atrial flutter and the new onset of atrial fibrillation. Overall, 82% (297 of 363) of the patients experienced new onset of drug refractory atrial fibrillation. Left-atrial size was a predictor of atrial fibrillation recurrence post-atrial flutter ablation. CONCLUSION: At long-term follow-up, approximately 82% of patients post-cavotricuspid isthmus ablation for atrial flutter developed drug refractory atrial fibrillation. This finding suggests that elimination of atrial flutter might delay, but does not prevent, atrial fibrillation. Evidence suggests both arrhythmias may share common triggers and such patients may derive a better long-term benefit from anatomical ablative treatment of atrial fibrillation as well.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1540-8167.2007.00885.x

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 19 references

Cited by

Sorted by citations

Items 101–133 of 133

Related

See all

Metadata

Authors
ELLIS, K., WAZNI, O., MARROUCHE, N., MARTIN, D., GILLINOV, M., McCARTHY, P., SAAD, E. B., BHARGAVA, M., SCHWEIKERT, R., SALIBA, W., BASH, D., ROSSILLO, A., ERCIYES, D., TCHOU, P., & NATALE, A.
Affiliations
Cleveland Clinic (US)
Corresponding author
NATALE, ANDREA
ORCID
Venue
Journal of Cardiovascular Electrophysiology
Publisher
Wiley
Published
2007-06-25
Volume
18
Issue
8
Pages
799-802
ISSN
  • 1045-3873 (ISSN-L)
  • 1540-8167
DOI
10.1111/j.1540-8167.2007.00885.x
OpenAlex
W2060097624
Cited by
134
References
19
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 9 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 8 · 2015: 15 · 2014: 9 · 2013: 10 · 2012: 6
FWCI
6.34
Type
journal article
Language
en
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations
  • Journal of Cardiovascular Electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
atrial fibrillation, atrial flutter, cavotricuspid isthmus ablation, left atrial size, atrial fibrillation recurrence, drug-refractory atrial fibrillation, long-term follow-up, left ventricular ejection fraction, atrial fibrillation triggers
MeSH terms
Anti-Arrhythmia Agents, Atrial Fibrillation, Atrial Flutter, Female, Heart Atria, Humans, Male, Middle Aged, Ohio, Prognosis, Recurrence, Risk Factors, Sensitivity and Specificity, Tricuspid Valve, Reproducibility of Results, Comorbidity, Incidence, Catheter Ablation, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review